- What measures should be considered in this 2022–2023 winter season
-
Lee JK
- KMID: 2534845
- Osong Public Health Res Perspect.
- 2022 Oct;13(5):313-315.
- doi: 10.24171/j.phrp.2022.0286
-
- CITED
-
- Close
- SHARE
-
- Close
- Zika virus as an emerging arbovirus of international public health concern
-
Vaziri S, Hamzeh Pour S, Akrami-Mohajeri F
- KMID: 2534837
- Osong Public Health Res Perspect.
- 2022 Oct;13(5):341-351.
- doi: 10.24171/j.phrp.2022.0101
Zika virus (ZIKV) was identified in 1947 in a rhesus monkey during an investigation of the yellow fever virus in the Zika Forest of Uganda; it was also isolated later... -
- CITED
-
- Close
- SHARE
-
- Close
- Presumed population immunity to SARS-CoV-2 in South Korea, April 2022
-
Jang EJ, Choe YJ, Choe SA, Kim YY, Kim RK, Kim J, Lim DS, Lee JH, Yi S, Lee S, Park YJ
- KMID: 2534843
- Osong Public Health Res Perspect.
- 2022 Oct;13(5):377-381.
- doi: 10.24171/j.phrp.2022.0209
Objectives : We estimated the overall and age-specific percentages of the Korean population with presumed immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as of April 2022 using... -
- CITED
-
- Close
- SHARE
-
- Close
- India’s efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review
-
Singh K, Verma A, Lakshminarayan M
- KMID: 2534838
- Osong Public Health Res Perspect.
- 2022 Oct;13(5):316-327.
- doi: 10.24171/j.phrp.2022.0104
The initial case of coronavirus disease 2019 (COVID-19) in India was reported on January 30, 2020, and subsequently, the number of COVID-19-infected patients surged during the first wave of April 2020 and... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of medication adherence interventions for older adults with chronic illnesses: a systematic review and meta-analysis
-
Jeon HO, Chae MO, Kim A
- KMID: 2534841
- Osong Public Health Res Perspect.
- 2022 Oct;13(5):328-340.
- doi: 10.24171/j.phrp.2022.0168
This systematic review and meta-analysis aimed to understand the characteristics of medication adherence interventions for older adults with chronic illnesses, and to investigate the average effect size by combining the... -
- CITED
-
- Close
- SHARE
-
- Close
- A case-control study of acute hepatitis A in South Korea, 2019
-
Hyun JH, Yoon JY, Lee SH
- KMID: 2534840
- Osong Public Health Res Perspect.
- 2022 Oct;13(5):352-359.
- doi: 10.24171/j.phrp.2022.0141
Objectives: We aimed to reconfirm the source of hepatitis A virus (HAV) infection through epidemiological and genotype investigations of individual cases in a 2019 outbreak in South Korea. Methods: We investigated food... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical outcomes of remdesivir-treated COVID-19 patients in South Korea
-
Yu M, Kim BI, Kim J, Gwack J
- KMID: 2534839
- Osong Public Health Res Perspect.
- 2022 Oct;13(5):370-376.
- doi: 10.24171/j.phrp.2022.0138
Objectives: This study analyzed the clinical outcomes of remdesivir treatment in coronavirus disease 2019 (COVID-19) patients in South Korea. Methods: This retrospective cohort study involved the secondary analysis of epidemiological data.... -
- CITED
-
- Close
- SHARE
-
- Close
- Adverse events of the Pfizer-BioNTech COVID-19 vaccine in Korean children and adolescents aged 5 to 17 years
-
Lee YK
- KMID: 2534844
- Osong Public Health Res Perspect.
- 2022 Oct;13(5):382-390.
- doi: 10.24171/j.phrp.2022.0233
Objectives: This study aimed to identify potential safety signals and adverse events following the primary Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccination series among children and adolescents aged 5 to 17... -
- CITED
-
- Close
- SHARE
-
- Close
- Investigation of SARS-CoV-2 lineages and mutations circulating in a university-affiliated hospital in South Korea analyzed using Oxford Nanopore MinION sequencing
-
Kim H, Chung SH, Kim HS, Kim HS, Song W, Hong KH, Kim JS
- KMID: 2534842
- Osong Public Health Res Perspect.
- 2022 Oct;13(5):360-369.
- doi: 10.24171/j.phrp.2022.0183
Objectives: Despite the introduction of vaccines, treatments, and massive diagnostic testing, the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has continued to overcome barriers that had slowed its... -
- CITED
-
- Close
- SHARE
-
- Close
